Search

Your search keyword '"*NEW product development laws"' showing total 1 results

Refine your results

1 results on '"*NEW product development laws"'

1. Seeking approval: For new drugs and devices, a faster track to market often found in Europe.

Author

Lee, Jaimy

Subjects
*ANTINEOPLASTIC agents, *DIFFUSION of innovations, *MEDICAL equipment, *HEALTH policy, *PHARMACEUTICAL industry, *TIME, *NEW product development laws, *GOVERNMENT regulation, *DRUG approval
Abstract

The article discusses why drug companies and medical device manufacturers in the U.S. are focusing to market in Europe. According to Delcath President and chief executive officer (CEO) Eamonn Hobbs, there is a difficult regulatory environment in the U.S., making it difficult to bring new drug and device technologies. A report from California Healthcare Institute and the Boston Consulting Group has found that by 2007, new drugs were approved two months faster in the European Union, in comparison to the U.S.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results